Carbon Monoxide Modulation of Microglia-Neuron Communication: Anti-Neuroinflammatory and Neurotrophic Role

Nuno L Soares1, Inês Paiva1,2, Joana Bravo3

  • 1CEDOC-Faculdade de Ciências Médicas/NOVA Medical School, Universidade Nova de Lisboa, Lisbon, Portugal.

Molecular Neurobiology
|November 19, 2021
PubMed

Insights

Carbon monoxide (CO) protects neurons by modulating microglia communication. CO-treated microglia release factors that reduce inflammation and enhance neuronal health, offering a novel therapeutic avenue for CNS disorders.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Microglia, the immune cells of the central nervous system (CNS), are crucial for brain health but can cause neuroinflammation when dysfunctional.
  • Exacerbated neuroinflammation is a key factor in CNS disorder pathology, necessitating strategies to modulate microglial activity.
  • Carbon monoxide (CO), an endogenous gas, exhibits anti-inflammatory and cytoprotective properties.

Purpose of the Study:

  • To investigate the role of CO in modulating microglia-to-neuron communication.
  • To assess the neuroprotective effects of a novel CO-releasing molecule, ALF-826A, on neuronal health.
  • To elucidate the mechanisms underlying CO-mediated neuroprotection in neuron-microglia interactions.

Main Methods:

  • Utilized primary rat microglia and neuron cultures, alongside BV-2 microglial and CAD neuronal cell lines.
  • Employed microglial-derived conditioned media to study indirect neuron-microglia communication.
  • Assessed neuroprotection against lipopolysaccharide (LPS)-induced inflammation and tert-Butyl hydroperoxide (t-BHP) oxidative stress.

Main Results:

  • Conditioned media from CO-treated microglia conferred neuroprotection against LPS-induced inflammation, reducing microglial reactivity, reactive oxygen species (ROS), and inflammatory factors.
  • CO-treated microglia-conditioned media improved neuronal morphological complexity under basal conditions and protected against t-BHP-induced cell death.
  • ALF-826A treatment increased microglia secretion of Interleukin-10 (IL-10) and adenosine; adenosine receptor antagonism reversed CO-derived neuroprotection.

Conclusions:

  • CO modulates microglia-to-neuron communication, providing non-cell autonomous neuroprotection.
  • CO enhances microglial release of neurotrophic factors and suppresses excessive microglial inflammation.
  • CO's neuroprotective effects involve purinergic signaling via adenosine receptors, representing a novel therapeutic strategy for CNS disorders.